Evidence map›Paper›PMID 30073203›Full record

ArticlemSystems

Combinatorial Approaches to Viral Attenuation.

Matthew L Paff, Benjamin R Jack, Bartram L Smith, James J Bull, Claus O Wilke

Open access · goldAbstract read
In one paragraph

Article in mSystems. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Matthew L PaffDepartment of Integrative Biology, The University of Texas at Austin, Austin, Texas, USA.
Benjamin R JackDepartment of Integrative Biology, The University of Texas at Austin, Austin, Texas, USA.
Bartram L SmithDepartment of Integrative Biology, The University of Texas at Austin, Austin, Texas, USA.
James J BullDepartment of Integrative Biology, The University of Texas at Austin, Austin, Texas, USA.
Claus O WilkeDepartment of Integrative Biology, The University of Texas at Austin, Austin, Texas, USA.ORCID https://orcid.org/0000-0002-7470-9261
The University of Texas at Austin · US

Funding

The biophysical basis of translational selectionR01GM088344 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI BARRICK, JEFFREY EVAN, WILKE, CLAUS O · 2009 to 2023
$3.5M
Identifying Mutations that Promote Microbial EvolvabilityK99GM087550 · NIGMS · MICHIGAN STATE UNIVERSITY · PI BARRICK, JEFFREY EVAN · 2009 to 2010
$180k
NIGMS NIH HHS K99 GM087550NIGMS NIH HHS R01 GM088344
6 · The paper itself

Abstract

Attenuated viruses have numerous applications, in particular in the context of live viral vaccines. However, purposefully designing attenuated viruses remains challenging, in particular if the attenuation is meant to be resistant to rapid evolutionary recovery. Here we develop and analyze a new attenuation method, promoter ablation, using an established viral model, bacteriophage T7. Ablation of promoters of the two most highly expressed T7 proteins (scaffold and capsid) led to major reductions in transcript abundance of the affected genes, with the effect of the double knockout approximately additive of the effects of single knockouts. Fitness reduction was moderate and also approximately additive; fitness recovery on extended adaptation was partial and did not restore the promoters. The fitness effect of promoter knockouts combined with a previously tested codon deoptimization of the capsid gene was less than additive, as anticipated from their competing mechanisms of action. In one design, the engineering created an unintended consequence that led to further attenuation, the effect of which was studied and understood in hindsight. Overall, the mechanisms and effects of genome engineering on attenuation behaved in a predictable manner. Therefore, this work suggests that the rational design of viral attenuation methods is becoming feasible.

Indexed as

bacteriophagescodon deoptimizationpromoter knockoutviral attenuation

Identifiers

PMID30073203
PMCPMC6068830
OpenAlexW2952584830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.